News
-
-
PRESS RELEASE
Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH – Strategic step toward integrated platform for cold plasma technology
Viromed Medical AG signs letter of intent to acquire relyon plasma GmbH, a key strategic step towards an integrated platform for cold plasma technology. The acquisition aims to strengthen Viromed's technological position and expand its market presence -
-
-
-
PRESS RELEASE
Viromed Medical AG: Globally unique preclinical data base – Saarland validation as key step toward first physical lung application
Viromed Medical AG presents globally unique preclinical data on cold plasma therapy for lung infections, with Saarland validation confirming a key step towards clinical application -
-
-
-
